Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post-mass drug ad ministration surveillance in American Samoa
- PMID: 35150913
- PMCID: PMC8948089
- DOI: 10.1016/j.ijid.2022.02.006
Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post-mass drug ad ministration surveillance in American Samoa
Abstract
Background: Under the Global Programme to Eliminate Lymphatic Filariasis (LF), American Samoa conducted 7 rounds of mass drug administration (MDA) between 2000 and 2006. The territory passed transmission assessment surveys (TASs) in 2011 (TAS-1) and 2015 (TAS-2). In 2016, the territory failed TAS-3, indicating resurgence. This study aims to determine if antibodies (Abs) may have provided a timelier indication of LF resurgence in American Samoa.
Methods: We examined school-level antigen (Ag) and Ab status (presence/absence of Ag- and Ab-positive children) and prevalence of single and combined Ab responses to Wb123, Bm14, and Bm33 Ags at each TAS. Pearson chi-square test and logistic regression were used to examine associations between school-level Ab prevalence in TAS-1 and TAS-2 and school-level Ag status in TAS-3.
Results: Schools with higher prevalence of Wb123 Ab in TAS-2 had higher odds of being Ag-positive in TAS-3 (odds ratio [OR] 24.5, 95% confidence interval [CI] 1.2-512.7). Schools that were Ab-positive for WB123 plus Bm14, Bm33, or both Bm14 and Bm33 in TAS-2 had higher odds of being Ag-positive in TAS-3 (OR 16.0-24.5).
Conclusion: Abs could provide earlier signals of resurgence and enable a timelier response. The promising role of Abs in surveillance after MDA and decision making should be further investigated in other settings.
Keywords: American Samoa; Antifilarial antibodies; Lymphatic filariasis; Lymphatic filariasis resurgence; Post–mass drug administration; Transmission assessments surveys.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures





References
-
- Abbott. ALERE™ FILARIASIS TEST STRIP; Available from: https://www.globalpointofcare.abbott/en/product-details/alere-filariasis.... html#:∼:text=Alere%E2%84%A2%20Filariasis%20Test%20Strip,filarial%20antig.... [Accessed 26/02/2021].
-
- Amerika Samoa Department of Education. American Samoa Elementary schools; 2020. Available from: https://www.doe.as/District/Schools. [Accessed 02/12/2020].
-
- Centers for Disease Control and Prevention (CDC). Lymphatic filariasis: Epidemilogy and risk factors; Available from: https://www.cdc.gov/parasites/lymphaticfilariasis/epi.html. [Accessed 08/12/2020].
-
- Dolo H, Coulibaly YI, Dembele B, Guindo B, Coulibaly SY, Dicko I, et al. Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test. PLoS Negl Trop Dis. 2019;13(1) - PMC - PubMed
-
- ESRI . Redlands; California: 2019. Environmental Systems Research Institute. ArcGIS Software version 10.7.1.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources